The sale of the U.S. and U.K. operations of WuXi Advanced Therapies, WuXi AppTec’s cell and gene therapy manufacturing arm, is for an undisclosed amount.
Under the deal, Akums Drugs & Pharmaceuticals will manufacture select oral liquid formulations to be marketed in multiple European countries by the undisclosed company.